ASX Stock Types | Actionable Investment Insights

Insights

Videos

Pricing

About us

Has Neuren Pharmaceuticals' (NEU) share price bottomed out?

Mar 1, 2026

Proactive Equities Team

If you bought Neuren Pharmaceuticals (ASX: NEU) near its peak, the recent volatility has been uncomfortable. Despite having its first approved drug for a rare paediatric disorder, growing royalty income and a promising pipeline, the share price has repeatedly rallied and retraced over the past two years. The key question now is whether NEU has already formed a durable bottom — or if another leg down could still test investor conviction.

Fortescue Ltd (ASX: FMG): Strong Cash Flows and Dividends in a Cyclical Iron Ore Market

Mar 1, 2026

Proactive Equities Team

Fortescue Ltd is a low-cost iron ore producer with strong cash flow and attractive fully franked dividends, but earnings remain highly exposed to iron ore prices and Chinese demand. Trading around mid-cycle valuation levels, the stock looks fairly valued, with upside dependent on stronger commodity prices and successful expansion into magnetite and green energy.

WiseTech Global (ASX: WTC) – Testing the $2bn Strategic Gamble

Feb 27, 2026

Proactive Equities Team

WiseTech Global’s A$2bn acquisition of E2open has significantly boosted revenue but diluted margins and increased leverage, shifting the investment case from premium organic growth to execution-driven integration. While the long-term strategic rationale remains sound, near-term earnings pressure and higher balance sheet risk make valuation more demanding and leave little room for integration missteps.

Has PolyNovo's (ASX: PNV) share price hit the bottom yet?

Feb 27, 2026

Proactive Equities Team

PolyNovo Limited (ASX: PNV) remains a fundamentally strong, high-growth medtech, but its share price is currently testing key support around A$0.88–0.92 within a broader sideways range. While selling pressure has eased and momentum is stabilising, a confirmed bottom would require a sustained break above A$1.08; otherwise, a fall below A$0.86–0.90 could signal further downside.

Westpac Banking Corporation (ASX: WBC) – Capital Strength and Dividend Appeal in a Low-Growth Environment

Feb 26, 2026

Proactive Equities Team

Westpac Banking Corporation is a systemically important bank with a strong mortgage franchise, solid capital buffers and a fully franked dividend. With modest 3–4% earnings growth expected, current valuations look full, making it more suited to income investors than deep-value buyers.

Silver’s On the Move Again: Is Investigator Silver (IVR) Worth Another Look?

Feb 26, 2026

Proactive Equities Team

Silver has rebounded sharply after a brutal 30–40% pullback, driven by geopolitical tensions and renewed macro uncertainty. Against this backdrop, Investigator Resources Ltd (ASX: IVR) — whose share price has more than tripled over the past year — has pulled back from recent highs as traders de-risk. The key question now is whether silver’s renewed surge signals another leg higher, offering leveraged upside for IVR, or just more short-term volatility.